PHYSIONEAL 40 glukoza 3,86% w/v 38.6 g/1 L+ 5.38 g/1 L+ 0.184 g/1 L+ 0.051 g/1 L+ 2.1 g/1 L+ 1.68 g/1 L rastvor za peritonealnu Bosnia y Herzegovina - croata - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

physioneal 40 glukoza 3,86% w/v 38.6 g/1 l+ 5.38 g/1 l+ 0.184 g/1 l+ 0.051 g/1 l+ 2.1 g/1 l+ 1.68 g/1 l rastvor za peritonealnu

co.medprom d.o.o. banja luka - glukoza, kalcijumhlorid, magnezijumhlorid, natrijum bikarbonat, natrijumhlorid, natrijumlaktat - rastvor za peritonealnu dijalizu - 38.6 g/1 l+ 5.38 g/1 l+ 0.184 g/1 l+ 0.051 g/1 l+ 2.1 g/1 l+ 1.68 g/1 l - nakon mješanja rastvora iz komora a i b, 1 l rastvora za peritonealnu dijalizu sadrži: 38,6 g glukoze (u obliku glukoze monohidrata) 5,38 g natrijum hlorida 0,184 g kalcijumhlorid, dihidrata 0,051 g magnezijumhlorid heksahidrata 2,10 g natrijum bikarbonata 1,68 g natrijum laktata

ADVANTIX Spot-on za pse od 25 do 40 kg Croacia - croata - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

advantix spot-on za pse od 25 do 40 kg

bayer animal health gmbh, 51368 leverkusen, njemačka - imidakloprid; permetrin - otopina za nakapavanje na kožu - pasa (od 25 do 40 kg)

GLUKOZA 40% B. Braun 440 mg/1 mL Koncentrat za otopinu za infuziju Bosnia y Herzegovina - croata - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

glukoza 40% b. braun 440 mg/1 ml koncentrat za otopinu za infuziju

b.braun adria bh d.o.o. - glukoza - koncentrat za otopinu za infuziju - 440 mg/1 ml - 1 ml koncentrat za otopinu za infuziju sadrži: 400 mg glukoze što odgovara 440 mg glukoza monohidrata 100 ml koncentrat za otopinu za infuziju sadrži: 40 g glukoza što odgovara 44 g glukoza monohidrata

KREON 40 000 400mg Gastrorezistentna kapsula, tvrda Montenegro - croata - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

kreon 40 000 400mg gastrorezistentna kapsula, tvrda

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - pankreatin - gastrorezistentna kapsula, tvrda - 400mg

ADVANTIX Spot-on za pse od 40 do 60 kg Croacia - croata - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

advantix spot-on za pse od 40 do 60 kg

bayer animal health gmbh, 51368 leverkusen, njemačka - imidakloprid; permetrin - otopina za nakapavanje - imidakloprid permetrin - pasa (od 40 kg do 60 kg)

Tisseel Lyo prašci i otapala za tkivno ljepilo Croacia - croata - HALMED (Agencija za lijekove i medicinske proizvode)

tisseel lyo prašci i otapala za tkivno ljepilo

baxter d.o.o., letališka cesta 29a, ljubljana, slovenija - fibrinogen, ljudski aprotinin trombin, ljudski kalcijev klorid dihidrat - prašak i otapalo za tkivno ljepilo - 91 mg/ml + 3000 kiu/ml + 500 iu/ml + 40 µmol/ml - urbroj: komponenta 1: otopina proteina tkivnog ljepila (koncentrat proteina tkivnog ljepila (tisseel prašak, liofilizirani), rekonstituiran s otopinom aprotinina); fibrinogen, ljudski (protein koji sudjeluje u zgrušavanju) 91 mg/ml; aprotinin, sintetski 3000 kiu/ml; komponenta 2: otopina trombina trombin (prašak trombina, liofilizirani), rekonstituiran s otopinom kalcijevog klorida; trombin, ljudski 500 iu/ml; kalcijev klorid dihidrat 40 µmol/ml; 1, 2 ili 5 ml otopine proteina tkivnog ljepila i 1, 2 ili 5 ml otopine trombina miješanjem daju 2, 4 ili 10 ml otopine spremne za uporabu tisseel lyo sadrži ljudski koagulacijski faktor xiii (istovremeno izdvojen s ljudskim fibrinogenom) u rasponu od 0,6 – 5 iu/ml.

Visomat comfort 20/40 Croacia - croata - HALMED (Agencija za lijekove i medicinske proizvode)

visomat comfort 20/40

oktal pharma d.o.o. utinjska 40 10000 zagreb -

DUOTRAV 40 µg/1 mL+ 5 mg/1 mL kapi za oko, otopina Bosnia y Herzegovina - croata - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

duotrav 40 µg/1 ml+ 5 mg/1 ml kapi za oko, otopina

novartis ba d.o.o. - timolol, травопрост - kapi za oko, otopina - 40 µg/1 ml+ 5 mg/1 ml - 1 ml kapi za oko, otopine sadrži: 40 mcg travoprost i 5 mg timolol (u obliku timololmaleata)

P3-TOPAX N 40 Croacia - croata - Ecolab

p3-topax n 40

ecolab deutschland gmbh -

Prezista Unión Europea - croata - EMA (European Medicines Agency)

prezista

janssen-cilag international nv - danmavir - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adult and paediatric patients from the age of 3 years and at least 15 kg body weight. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). in deciding to initiate treatment with prezista co administered with cobicistat or low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista 75 mg, 150 mg, and 600 mg tablets may be used to provide suitable dose regimens:for the treatment of hiv 1 infection in antiretroviral treatment (art) experienced adult patients, including those that have been highly pre treated. for the treatment of hiv 1 infection in paediatric patients from the age of 3 years and at least 15 kg body weight. in deciding to initiate treatment with prezista co administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents. genotypic or phenotypic testing (when available) and treatment history should guide the use of prezista. prezista, co administered with low dose ritonavir is indicated in combination with other antiretroviral medicinal products for the treatment of patients with human immunodeficiency virus (hiv 1) infection. prezista, co administered with cobicistat is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus (hiv 1) infection in adults and adolescents (aged 12 years and older, weighing at least 40 kg). prezista 400 mg and 800 mg tablets may be used to provide suitable dose regimens for the treatment of hiv 1 infection in adult and paediatric patients from the age of 3 years and at least 40 kg body weight who are:antiretroviral therapy (art) naïve. art experienced with no darunavir resistance associated mutations (drv rams) and who have plasma hiv 1 rna < 100,000 copies/ml and cd4+ cell count ≥ 100 cells x 106/l. in deciding to initiate treatment with prezista in such art experienced patients, genotypic testing should guide the use of prezista.